FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2758002845> ?p ?o ?g. }

• W2758002845 endingPage "e0185088" @default.
• W2758002845 startingPage "e0185088" @default.
• W2758002845 abstract "Sorafenib, an orally available kinase inhibitor, is the standard first-line systemic drug for advanced hepatocellular carcinoma (HCC), and it exerts potent inhibitory activity against epithelial-mesenchymal transition (EMT) and multidrug resistance (MDR) by inhibiting mitogen-activated protein kinase (MAPK) signaling in HCC. However, after long-term exposure to sorafenib, HCC cells exhibit EMT and resistance to sorafenib. The activation of AKT by sorafenib is thought to be responsible for the development of these characteristics. The present study aims to examine the underlying mechanism and seek potential strategies to reverse this resistance and the progression to EMT. Sorafenib-resistant cells showed increased metastatic and invasive ability, with a higher expression of P-glycoprotein (P-gp), compared with the parental cells. This phenomenon was at least partially due to EMT and the appearance of MDR in sorafenib-resistant HCC cells. Moreover, MDR was a downstream molecular event of EMT. Silencing Snail with siRNA blocked EMT and partially reversed the MDR, thereby markedly abolishing invasion and metastasis in sorafenib-resistant HCC cells, but silencing of MDR1 had no effect on the EMT phenotype. Additionally, HCC parental cells that were stably transfected with pCDNA3.1-Snail exhibited EMT and MDR. Two sorafenib-resistant HCC cell lines, established from human HCC HepG2 and Huh7 cells, were refractory to sorafenib-induced growth inhibition but were sensitive to MK-2206, a novel allosteric AKT inhibitor. Thus, the combination of sorafenib and MK-2206 led to significant reversion of the EMT phenotype and P-gp-mediated MDR by downregulating phosphorylated AKT. These findings underscore the significance of EMT, MDR and enhanced PI3K/AKT signaling in sorafenib-resistant HCC cells." @default.
• W2758002845 created "2017-10-06" @default.
• W2758002845 creator A5005808716 @default.
• W2758002845 creator A5051757715 @default.
• W2758002845 creator A5053624726 @default.
• W2758002845 creator A5060655239 @default.
• W2758002845 creator A5077069400 @default.
• W2758002845 creator A5091818733 @default.
• W2758002845 date "2017-09-21" @default.
• W2758002845 modified "2023-10-16" @default.
• W2758002845 title "Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells" @default.
• W2758002845 cites W1192308178 @default.
• W2758002845 cites W1584659685 @default.
• W2758002845 cites W1755917942 @default.
• W2758002845 cites W1822859171 @default.
• W2758002845 cites W1964081206 @default.
• W2758002845 cites W1969004585 @default.
• W2758002845 cites W1971180788 @default.
• W2758002845 cites W1971837077 @default.
• W2758002845 cites W1974741877 @default.
• W2758002845 cites W1976679129 @default.
• W2758002845 cites W1982604280 @default.
• W2758002845 cites W1990201193 @default.
• W2758002845 cites W1994193851 @default.
• W2758002845 cites W1996755755 @default.
• W2758002845 cites W1998203489 @default.
• W2758002845 cites W2011022187 @default.
• W2758002845 cites W2013078889 @default.
• W2758002845 cites W2018163822 @default.
• W2758002845 cites W2020224261 @default.
• W2758002845 cites W2030906616 @default.
• W2758002845 cites W2033413353 @default.
• W2758002845 cites W2035390577 @default.
• W2758002845 cites W2047172303 @default.
• W2758002845 cites W2048897980 @default.
• W2758002845 cites W2063488708 @default.
• W2758002845 cites W2072642940 @default.
• W2758002845 cites W2074420260 @default.
• W2758002845 cites W2077511002 @default.
• W2758002845 cites W2085002868 @default.
• W2758002845 cites W2090664023 @default.
• W2758002845 cites W2112796039 @default.
• W2758002845 cites W2118952669 @default.
• W2758002845 cites W2136615032 @default.
• W2758002845 cites W2140446354 @default.
• W2758002845 cites W2147748185 @default.
• W2758002845 cites W2151897898 @default.
• W2758002845 cites W2161555040 @default.
• W2758002845 cites W2174518609 @default.
• W2758002845 cites W2174734259 @default.
• W2758002845 cites W2211968863 @default.
• W2758002845 cites W2263265497 @default.
• W2758002845 cites W2406635079 @default.
• W2758002845 cites W2917837889 @default.
• W2758002845 cites W2591655368 @default.
• W2758002845 doi "https://doi.org/10.1371/journal.pone.0185088" @default.
• W2758002845 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5608310" @default.
• W2758002845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28934275" @default.
• W2758002845 hasPublicationYear "2017" @default.
• W2758002845 type Work @default.
• W2758002845 sameAs 2758002845 @default.
• W2758002845 citedByCount "81" @default.
• W2758002845 countsByYear W27580028452018 @default.
• W2758002845 countsByYear W27580028452019 @default.
• W2758002845 countsByYear W27580028452020 @default.
• W2758002845 countsByYear W27580028452021 @default.
• W2758002845 countsByYear W27580028452022 @default.
• W2758002845 countsByYear W27580028452023 @default.
• W2758002845 crossrefType "journal-article" @default.
• W2758002845 hasAuthorship W2758002845A5005808716 @default.
• W2758002845 hasAuthorship W2758002845A5051757715 @default.
• W2758002845 hasAuthorship W2758002845A5053624726 @default.
• W2758002845 hasAuthorship W2758002845A5060655239 @default.
• W2758002845 hasAuthorship W2758002845A5077069400 @default.
• W2758002845 hasAuthorship W2758002845A5091818733 @default.
• W2758002845 hasBestOaLocation W27580028451 @default.
• W2758002845 hasConcept C104317684 @default.
• W2758002845 hasConcept C119056186 @default.
• W2758002845 hasConcept C121608353 @default.
• W2758002845 hasConcept C126322002 @default.
• W2758002845 hasConcept C184235292 @default.
• W2758002845 hasConcept C185592680 @default.
• W2758002845 hasConcept C2778019345 @default.
• W2758002845 hasConcept C2778695046 @default.
• W2758002845 hasConcept C2779013556 @default.
• W2758002845 hasConcept C502942594 @default.
• W2758002845 hasConcept C55493867 @default.
• W2758002845 hasConcept C57074206 @default.
• W2758002845 hasConcept C62478195 @default.
• W2758002845 hasConcept C71924100 @default.
• W2758002845 hasConcept C75217442 @default.
• W2758002845 hasConcept C76419328 @default.
• W2758002845 hasConcept C86554907 @default.
• W2758002845 hasConcept C86803240 @default.
• W2758002845 hasConcept C95444343 @default.
• W2758002845 hasConceptScore W2758002845C104317684 @default.
• W2758002845 hasConceptScore W2758002845C119056186 @default.
• W2758002845 hasConceptScore W2758002845C121608353 @default.

• next